Kent A. Chambers PhD - SACS - Hardin-Simmons University
Kent A. Chambers PhD - SACS - Hardin-Simmons University
Kent A. Chambers PhD - SACS - Hardin-Simmons University
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Research Publications:<br />
Peer-reviewed:<br />
1. Chelvarajan RL, Collins SM, Doubinskaia IE, Goes S, Van Willigen J, Flanagan DL, De Villiers WJ,<br />
Bryson JS, Bondada S. (2004) Defective macrophage function in neonates and its impact on<br />
unresponsiveness of neonates to polysaccharide antigens. Journal of Leukocyte Biology. 75: 982-<br />
994.<br />
2. Flanagan DL, Jennings CD, Goes SW, Caywood BE, Gross R, Kaplan AM, Bryson JS. (2002) Nitric<br />
oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host<br />
disease. Journal of Leukocyte Biology. 72: 762-768.<br />
3. Flanagan DL, Gross R, Jennings CD, Caywood BE, Goes S, Kaplan AM, Bryson JS. (2001) Induction<br />
of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice. Journal of Leukocyte<br />
Biology. 70: 873-880.<br />
4. Bryson JS, Flanagan DL. (2000) Role of natural killer cells in the development of graft-versus-host<br />
disease. Journal of Hematotherapy and Stem Cell Research. 9: 307-316.<br />
5. Flanagan DL, Jennings CD, Bryson JS. (1999) TH1 cytokines and NK cells participate in the<br />
development of murine syngeneic graft-versus-host disease. Journal of Immunology. 163:1170<br />
6. Bryson JS, Jennings CD, Flanagan DL, Carlson SL, Pflugh DL, Caywood BE, Kaplan AM. (1999)<br />
Rejection of a MHC Class II negative tumor following induction of murine syngeneic graft-versus-host<br />
disease. Bone Marrow Transplantation. 23: 363.<br />
7. Bryson JS, Jennings CD, Caywood BE, Dix AR, Flanagan DL, Kaplan AM. (1997) Enhanced graft-<br />
versus-host disease in older recipient mice following allogeneic bone marrow transplantation. Bone<br />
Marrow Transplantation. 19: 721.<br />
Abstracts:<br />
1. Flanagan DL, Bryson JS. (1998) Macrophage-associated cytokines and the induction of murine<br />
syngeneic graft-versus-host disease. Autumn Immunology Conference. (Chicago) 27:77.<br />
2. Flanagan DL, Jennings CD, Carlson SL, Bryson JS. (1998) TH1-like cytokine response correlates<br />
with the development of murine syngeneic graft-versus-host disease. FASEB J. 12: A584, 339.<br />
3. Flanagan DL, Jennings CD, Carlson SL, Bryson JS. (1997) TH1-like cytokine response correlates<br />
with the development of murine syngeneic graft-versus-host disease. Autumn Immunology<br />
Conference (Chicago) 26: 83.<br />
4. Dix AR, Flanagan DL, Caywood BE, Reice DE, Bryson JS. (1996) Cyclosporine A-induced<br />
immunomodulation following autologous stem cell transplantation for chronic myelogenous leukemia.<br />
Autumn Immunology Conference (Chicago) 25: 71.<br />
5. Flanagan DL, Caywood BE, Bryson JS. (1996) Natural killer cells participate in the development of<br />
syngeneic graft-versus-host disease. FASEB J. A1195: 1129.<br />
6. Flanagan DL, Caywood BE, Bryson JS. (1995) Asialo-GM1 + cells participate in the development of<br />
syngeneic graft-versus-host disease. Autumn Immunology Conference (Chicago) 24:41.<br />
7. Bryson JS, Flanagan DL, Jennings CD, Caywood BE, Kaplan AM. (1995) Rejection of a MHC Class<br />
II negative tumor following induction of murine syngeneic graft-versus-host disease. 9 th International<br />
Congress of Immunology (San Francisco) 426.
Change language